As of Oct 21
| -0.03 / -0.21%|
The 5 analysts offering 12-month price forecasts for Insmed Inc have a median target of 21.00, with a high estimate of 24.00 and a low estimate of 13.00. The median estimate represents a +49.57% increase from the last price of 14.04.
The current consensus among 6 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.